Evidence map›Paper›PMID 30901820›Full record

ArticleMolecules (Basel, Switzerland)2019

Chemical Reactivity Theory and Empirical Bioactivity Scores as Computational Peptidology Alternative Tools for the Study of Two Anticancer Peptides of Marine Origin.

Juan Frau, Norma Flores-Holguín, Daniel Glossman-Mitnik

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Anticholinesterase activity ofFrontiers in pharmacology · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Computational Approaches for Drug Discovery.Molecules (Basel, Switzerland) · 2019
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Juan FrauDepartament de Química, Universitat de les Illes Balears, 07122 Palma de Mallorca, Spain. juan.frau@uib.es.
Norma Flores-HolguínLaboratorio Virtual NANOCOSMOS, Departamento de Medio Ambiente y Energía, Centro de Investigación en Materiales Avanzados, Miguel de Cervantes 120, Complejo Industrial Chihuahua, Chihuahua, Chih 31136, Mexico. norma.flores@cimav.edu.mx.ORCID 0000-0002-4836-233X
Daniel Glossman-MitnikDepartament de Química, Universitat de les Illes Balears, 07122 Palma de Mallorca, Spain. daniel.glossman@cimav.edu.mx.ORCID 0000-0002-9583-4256

Funding

Consejo Nacional de Ciencia y Tecnología 219566/2014Ministerio de Economía y Competitividad CTQ2014-55835-R
6 · The paper itself

Abstract

This work presents an account of the reactivity behavior of the anticancer marine drugs, Soblidotin and Tasidotin, based on the calculation of the global and local descriptors resulting from Chemical Reactivity Theory (CRT), also known as Conceptual DFT, for their consideration as a useful complement to approximations based on Molecular Docking. The information on the global and local reactivity descriptors of the Soblidotin and Tasidotin molecules, obtained through our proposed methodology, may be used for the design of new pharmaceutical analogs by relying on the chemical interactions between these peptides and their protein-type biological receptors. It can be concluded that the CRT approximation to the global and local chemical reactivity, based on the descriptors, can provide interesting information for the consideration of both molecules as potential therapeutic drugs. This is complemented by a study on Advanced Glycation Endproduct (AGE) inhibition, by comparison with the usual molecular systems considered for the task, as a re-purposing study. Finally, the bioactivity scores for Soblidotin and Tasidotin are predicted through an empirical procedure, based on comparison with molecular structures with well-known pharmacological properties.

Indexed as

Antimicrobial Cationic PeptidesAntineoplastic AgentsAquatic OrganismsGlycation End Products, AdvancedModels, MolecularMolecular ConformationPeptidesStructure-Activity RelationshipAntimicrobial Cationic PeptidesAntineoplastic AgentsGlycation End Products, AdvancedPeptidesAGEs inhibition abilitybioactivity scoreschemical reactivity theorypKasoblidotintasidotin

Identifiers

PMID30901820
PMCPMC6470772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.